Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $577,659 - $678,928
11,886 New
11,886 $664,000
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $80,971 - $111,321
1,674 New
1,674 $85,000
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $80,971 - $111,321
1,674 New
1,674 $85,000
Q1 2022

May 16, 2022

SELL
$71.02 - $86.99 $23,720 - $29,054
-334 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$76.72 - $92.68 $59,304 - $71,641
-773 Reduced 69.83%
334 $29,000
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $84,154 - $98,102
1,107 New
1,107 $88,000
Q2 2021

Aug 16, 2021

SELL
$73.44 - $87.01 $26,952 - $31,932
-367 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$62.9 - $82.41 $23,084 - $30,244
367 New
367 $27,000
Q4 2020

Feb 16, 2021

SELL
$46.01 - $68.74 $22,452 - $33,545
-488 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$41.91 - $57.81 $20,452 - $28,211
488 New
488 $22,000
Q1 2020

May 15, 2020

SELL
$34.22 - $76.49 $12,490 - $27,918
-365 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$68.92 - $85.27 $25,155 - $31,123
365 New
365 $28,000
Q3 2019

Nov 14, 2019

SELL
$71.74 - $86.35 $14,204 - $17,097
-198 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$66.45 - $97.36 $8,040 - $11,780
121 Added 157.14%
198 $14,000
Q1 2019

May 15, 2019

BUY
$86.15 - $100.49 $4,135 - $4,823
48 Added 165.52%
77 $7,000
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $57,046 - $85,034
-678 Reduced 95.9%
29 $3,000
Q3 2018

Nov 14, 2018

BUY
$101.02 - $130.95 $70,006 - $90,748
693 Added 4950.0%
707 $88,000
Q2 2018

Aug 14, 2018

SELL
$81.75 - $105.37 $327 - $421
-4 Reduced 22.22%
14 $1,000
Q1 2018

May 15, 2018

BUY
$79.95 - $89.74 $1,439 - $1,615
18 New
18 $2,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.52B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.